Variables | All patients (n = 123) | Normal ALT (n = 38) | Elevated ALT (n = 85) |
---|---|---|---|
Demographic characteristics | |||
Median age, years (range) | 35 (18–65) | 39 (23–61) | 33 (18–65) |
Males, n (%) | 85 (69.1) | 25 (65.8) | 60 (70.6) |
Laboratory data | |||
Median ALT, U/L (range) | 68.0 (5–483) | 24.5 (5–50) | 98 (51–483) |
Median AST, U/L (range) | 44.0 (15–323) | 23.0 (15–40) | 56 (27–323) |
HBeAg (+), n (%) | 66 (53.7) | 9 (23.7) | 57 (67.1) |
HBV DNA (mean ± SD), log10IU/ml | 5.99 ± 1.76 | 4.43 ± 1.79 | 6.67 ± 1.24 |
Liver histology | |||
Inflammation activity, n (%) | |||
G2, n (%) | 61 (87.1) | 20 (80.0) | 41 (91.1) |
G3, n (%) | 9 (12.9) | 5 (20.0) | 4 (8.9) |
Fibrosis (%) | |||
S1, n (%) | 22 (31.4) | 7 (28.0) | 15 (33.3) |
S2, n (%) | 37 (52.8) | 11 (44.0) | 26 (57.8) |
S3, n (%) | 11 (15.8) | 7 (28.0) | 4 (8.9) |